Validating Antibodies for Life Science Research
Science/AAAS webinar: Addressing the antibody reproducibility crisisHello Christian,
Join us for a live webinar presented by Mathias Uhlén, Ph.D. and Cecilia Williams, Ph.D. from the KTH Royal Institute of Technology, Stockholm.
The speakers will introduce the current concerns of the research community regarding antibody reproducibility, the efforts of the Human Protein Atlas project to characterize antibodies.
Date: April 11, 2018
Time: 9:00 am PDT/12:00 pm EDT/6:00 pm CEST
Duration: 60 minutesDuring the webinar you will learn about:
- The generation and validation of data used in the Human Protein Atlas
- Problems related to the cross-reactivity of antibodies and the challenges they create for the interpretation of results
- Enhanced validation of antibodies using five application-specific strategies
Since 2008, Merck has partnered with Atlas Antibodies to provide antibodies developed using the Human Protein Atlas to researchers around the world. The Human Protein Atlas displays a collection of over 13 million images of normal and cancer tissues, cell lines, and primary cells. This project has resulted in the development of 21,000 products that are some of the most highly characterized antibodies in the industry.
Your Merck Team